Romidepsin enhances the efficacy of cytarabine in vivo, revealing histone deacetylase inhibition as a promising therapeutic strategy for KMT2A-rearranged infant acute lymphoblastic leukemia

Haematologica. 2019 Jul;104(7):e300-e303. doi: 10.3324/haematol.2018.192906. Epub 2019 Jan 24.

¹ Division of Children's Leukaemia and Cancer Research, Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth.
² School of Pharmacy and Biomedical Sciences, Curtin University, Perth.
³ Children's Cancer Institute, Lowy Cancer Research Centre, UNSW, Sydney.
⁴ Division of Children's Leukaemia and Cancer Research, Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth [email protected].
⁵ Department of Haematology and Oncology, Perth Children's Hospital, Perth.
⁶ Division of Paediatrics, School of Medicine, University of Western Australia, Perth, Australia.

No abstract available

Publication types